Dyne Therapeutics Inc (DYN)
16.12
+3.73%
Dyne Therapeutics Inc (DYN) is currently trading at $16.12. This represents a gain of 3.73% from the previous session. With a market capitalization of $2.60B, DYN is a key component of the Health Care sector. Investors looking to trade DYN should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade DYN commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Dyne Therapeutics Inc (DYN) shows a bullish trend. Analysts are watching the 16.16 level closely.
Fundamentals
Mkt Cap2.60B
P/E Ratio0.0000
Volume1,706,088
60-Day Technical Chart
Advanced Charting
Need more indicators for DYN? Use the world's #1 platform.
Open DYN on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $16
| Metric |
DYN +3.73% |
WULF +0.80% |
HIMS +2.72% |
CIFR -2.98% |
|---|---|---|---|---|
| Price | $16.12 | $17.70 | $15.90 | $16.61 |
| Mkt Cap | $2.60B | $7.54B | $3.68B | $6.58B |
| - | View → | View → | View → |
Latest Headlines
Biotech Dyne Therapeutics heads to three March investor conferences
Stock Titan • Feb 25, 2026
$DYN stock is up 12% today. Here's what we see in our data. | DYN Stock News
Quiver Quantitative • Nov 17, 2025
New heart-lung data in rare muscle diseases: inside Dyne’s 2026 trial push
Stock Titan • Feb 22, 2026
Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate
Yahoo Finance • Dec 9, 2025
Dyne Therapeutics (DYN) Stock Sees Significant Drop
GuruFocus • Dec 9, 2025
● Gemini Agentic AI Analyst Insight for DYN
Market Education
- What Wolves Can Teach Us About Winning in the Markets Sep 8, 2025
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Bob Shiller got Nobel Prize - Efficient Frontier in Modern Portfolio Theory Jul 18, 2023
External Research